Article info
Inflammatory bowel disease
Original research
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
- Correspondence to Dr Kenneth Croitoru, Zane Cohen Centre for Digestive Diseases, Sinai Health System, Toronto, ON M5T 3L9, Canada; kcroitoru{at}mtsinai.on.ca
Citation
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
Publication history
- Received August 3, 2022
- Accepted January 25, 2023
- First published February 14, 2023.
Online issue publication
August 24, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.